Detalhe da pesquisa
1.
Racial Disparities in Documented Chief Complaints and Diagnoses in Sepsis Patients.
J Intensive Care Med
; 38(7): 630-634, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740933
2.
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.
J Virol
; 94(3)2020 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31694938
3.
Risk Factors for Early Treatment Discontinuation Due to Toxicity Among Patients With Metastatic Castration-resistant Prostate Cancer Receiving Androgen Receptor-targeted Therapy.
Am J Clin Oncol
; 47(6): 271-278, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344754
4.
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice.
bioRxiv
; 2022 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35350201
5.
Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.
Microbiol Spectr
; 10(3): e0153822, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658571
6.
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial.
EClinicalMedicine
; 45: 101323, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35284808
7.
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses.
Nat Commun
; 12(1): 6197, 2021 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707161
8.
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial.
medRxiv
; 2021 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580673
9.
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.
EBioMedicine
; 62: 103132, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33232870
10.
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.
bioRxiv
; 2020 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32743571
11.
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine.
Vaccines (Basel)
; 8(4)2020 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33348607
12.
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine.
bioRxiv
; 2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766572
13.
Things We Do for No Reason™: Routine preoperative hemostatic testing for neurosurgical procedures.
J Hosp Med
; 18(8): 745-747, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36380658
14.
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
Nat Commun, v. 12, 6197, out. 2021
Artigo
em Inglês
| SES-SP, SESSP-IBPROD, SES-SP | ID: bud-4045